Trevi Therapeutics, Inc. Shares Outstanding (Cover Page)
Trevi Therapeutics, Inc. (TRVI) had Shares Outstanding (Cover Page) of 142.48 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 142.48M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 141.98M shares.
- 2026-03-12: Entity Common Stock, Shares Outstanding 128.40M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 128.23M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 142.48M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 141.98M shares 10-Q · filed 2026-05-05 |
| 2026-03-12 | 128.40M shares 10-K · filed 2026-03-17 |
| 2025-10-31 | 128.23M shares 10-Q · filed 2025-11-13 |
| 2025-07-31 | 121.78M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 101.74M shares 10-Q · filed 2025-05-08 |
| 2025-03-14 | 96.68M shares 10-K · filed 2025-03-18 |
| 2024-10-31 | 76.87M shares 10-Q · filed 2024-11-06 |
| 2024-07-31 | 72.59M shares 10-Q · filed 2024-08-08 |
| 2024-05-07 | 70.44M shares 10-Q · filed 2024-05-07 |
| 2024-03-20 | 68.96M shares 10-K · filed 2024-03-20 |
| 2023-11-09 | 63.86M shares 10-Q · filed 2023-11-09 |
| 2023-08-10 | 63.85M shares 10-Q · filed 2023-08-10 |
| 2023-05-11 | 60.07M shares 10-Q · filed 2023-05-11 |
| 2023-03-16 | 60.05M shares 10-K · filed 2023-03-16 |
| 2022-11-10 | 59.92M shares 10-Q · filed 2022-11-10 |
| 2022-08-11 | 42.77M shares 10-Q · filed 2022-08-11 |
| 2022-05-12 | 38.69M shares 10-Q · filed 2022-05-12 |
| 2022-03-17 | 30.81M shares 10-K · filed 2022-03-17 |
| 2021-11-10 | 25.85M shares 10-Q · filed 2021-11-10 |
| 2021-08-12 | 21.60M shares 10-Q · filed 2021-08-12 |
| 2021-05-12 | 19.93M shares 10-Q · filed 2021-05-13 |
| 2021-03-24 | 19.91M shares 10-K · filed 2021-03-25 |
| 2020-11-11 | 18.38M shares 10-Q · filed 2020-11-12 |
| 2020-08-13 | 18.24M shares 10-Q · filed 2020-08-13 |
| 2020-05-07 | 17.83M shares 10-Q · filed 2020-05-07 |
| 2020-03-13 | 17.83M shares 10-K · filed 2020-03-16 |
| 2019-11-14 | 17.83M shares 10-Q · filed 2019-11-14 |
| 2019-08-12 | 17.83M shares 10-Q · filed 2019-08-12 |
| 2019-06-13 | 17.83M shares 10-Q · filed 2019-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |